Literature DB >> 9628444

Hepatocellular carcinoma in children associated with Gardner syndrome or familial adenomatous polyposis.

B A Gruner1, T S DeNapoli, W Andrews, G Tomlinson, L Bowman, S D Weitman.   

Abstract

PURPOSE: Gardner syndrome, a variant of familial adenomatous polyposis, is characterized by colonic polyps that undergo malignant change and benign and malignant extracolonic lesions. Tumors frequently associated with Gardner syndrome include carcinoma of the ampulla of Vater, papillary carcinoma of the thyroid, and, in children, hepatoblastoma. The childhood malignancies often precede the appearance of other manifestations by several years. PATIENTS AND METHODS: Two patients are described. Gardner syndrome was diagnosed in a 15-year-old girl with fibrolamellar hepatocellular carcinoma after desmoid tumors and colonic polyposis developed. Classic hepatocellular carcinoma was also diagnosed in a 9 1/2-year-old boy with familial adenomatous polyposis.
RESULTS: In patient 1, the diagnosis of fibrolamellar hepatocellular carcinoma preceded the diagnosis of Gardner syndrome by almost 2 years. The diagnosis was confirmed by identifying a germline mutation of the adenomatous polyposis coli (APC) gene. This is the first patient reported with fibrolamellar hepatocellular carcinoma associated with Gardner syndrome. Patient 2 had a strong family history of familial adenomatous polyposis but no manifestations of Gardner syndrome. He was not tested for the APC mutation. The current literature and previously reported cases of hepatocellular carcinoma in patients with Gardner syndrome or familial adenomatous polyposis are reviewed.
CONCLUSIONS: Because hepatocellular carcinoma is uncommon in the pediatric and adolescent population, it is important to consider the possibility of Gardner syndrome or familial adenomatous polyposis in these patients.

Entities:  

Mesh:

Year:  1998        PMID: 9628444     DOI: 10.1097/00043426-199805000-00018

Source DB:  PubMed          Journal:  J Pediatr Hematol Oncol        ISSN: 1077-4114            Impact factor:   1.289


  7 in total

Review 1.  Hepatocelluar carcinoma associated with attenuated familial adenomatous polyposis: a case report and review of the literature.

Authors:  Mingqing Li; David A Gerber; Mark Koruda; Bert H O'Neil
Journal:  Clin Colorectal Cancer       Date:  2011-08-02       Impact factor: 4.481

2.  Liver-targeted disruption of Apc in mice activates beta-catenin signaling and leads to hepatocellular carcinomas.

Authors:  S Colnot; T Decaens; M Niwa-Kawakita; C Godard; G Hamard; A Kahn; M Giovannini; C Perret
Journal:  Proc Natl Acad Sci U S A       Date:  2004-11-24       Impact factor: 11.205

3.  The association of family history of liver cancer with hepatocellular carcinoma: a case-control study in the United States.

Authors:  Manal M Hassan; Margret R Spitz; Melanie B Thomas; Steven A Curley; Yehuda Z Patt; Jean-Nicolas Vauthey; Katrina Y Glover; Ahmed Kaseb; Richard D Lozano; Adel S El-Deeb; Nga T Nguyen; Steven H Wei; Wenyaw Chan; James L Abbruzzese; Donghui Li
Journal:  J Hepatol       Date:  2008-10-16       Impact factor: 25.083

Review 4.  The adenomatous polyposis coli tumor suppressor and Wnt signaling in the regulation of apoptosis.

Authors:  Hassina Benchabane; Yashi Ahmed
Journal:  Adv Exp Med Biol       Date:  2009       Impact factor: 2.622

Review 5.  Fibrolamellar carcinoma: 2012 update.

Authors:  Michael Torbenson
Journal:  Scientifica (Cairo)       Date:  2012-09-23

6.  Familial adenomatous polyposis of the colon.

Authors:  Andrzej Plawski; Tomasz Banasiewicz; Pawel Borun; Lukasz Kubaszewski; Piotr Krokowicz; Marzena Skrzypczak-Zielinska; Jan Lubinski
Journal:  Hered Cancer Clin Pract       Date:  2013-10-22       Impact factor: 2.857

7.  From the Gut to the Liver: Another Organ to Watch in FAP Patients.

Authors:  Spencer Paulson; Charmi Patel; Hitendra Patel
Journal:  Case Rep Pathol       Date:  2016-03-24
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.